Femasys【FEMY】株式ニュース

名称	銘柄コード	市場	種別
Femasys Inc	FEMY	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	0.00	0.00%	1.18	09:00:00

始値	安値	高値	終値	前日終値
1.19	1.1745	1.22	1.18	1.18

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/5/17	21:30	GLOBE	Femasys CEO and Founder Kathy Lee-Sepsick Meets with the..
2024/5/16	21:30	GLOBE	Femasys CEO and Founder Kathy Lee-Sepsick Meets with the..
2024/5/09	21:40	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/09	21:35	EDGAR2	Form 8-K - Current report
2024/5/09	21:30	GLOBE	Femasys Announces Financial Results for Quarter Ended March..
2024/5/07	21:30	GLOBE	Femasys Expands Commercial Management Team with Addition of..
2024/4/18	21:30	GLOBE	Femasys CEO and Founder Kathy Lee-Sepsick Meets with Members..
2024/3/29	05:05	GLOBE	Femasys Announces Financial Results for Year Ended December..
2024/3/21	22:00	GLOBE	Femasys Invites Investors to View Fireside Chat Today, March..
2024/3/20	21:15	GLOBE	Femasys Announces Positive Topline Data from Pivotal Trial..
2024/3/13	22:00	GLOBE	Femasys to Participate in Fireside Chat to Discuss the..
2024/3/06	23:09	EDGAR2	Form 8-K - Current report
2024/3/06	23:00	GLOBE	Femasys Completes the First In-Office Commercial Procedure..
2024/2/28	23:16	EDGAR2	Form 8-K - Current report
2024/2/14	11:47	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/14	11:44	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
2024/2/06	22:47	EDGAR2	Form 8-K - Current report
2024/2/03	06:43	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/03	06:42	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/03	06:42	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/11	14:15	EDGAR2	Form EFFECT - Notice of Effectiveness
2023/12/08	23:28	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/12/01	07:17	EDGAR2	Form S-3 - Registration statement under Securities Act of..
2023/11/30	06:05	EDGAR2	Form 8-K - Current report
2023/11/23	06:39	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/11/23	06:33	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
2023/11/22	07:30	EDGAR2	Form 8-K - Current report
2023/11/16	07:19	EDGAR2	Form 8-K - Current report
2023/11/15	22:30	BW	PharmaCyte Biotech Acquires $5 Million Stake in Emerging..
2023/11/02	10:40	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/10/11	21:01	EDGAR2	Form 8-K - Current report
2023/10/03	22:28	EDGAR2	Form 8-K - Current report
2023/10/03	22:27	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/9/27	21:19	EDGAR2	Form 8-K - Current report
2023/9/07	06:00	EDGAR2	Form 8-K - Current report
2023/8/10	21:11	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/10	21:05	EDGAR2	Form 8-K - Current report
2023/8/07	21:40	EDGAR2	Form DEF 14A - Other definitive proxy statements
2023/8/03	22:04	EDGAR2	Form 8-K - Current report
2023/7/29	06:15	EDGAR2	Form PRE 14A - Other preliminary proxy statements
2023/7/27	22:04	EDGAR2	Form 8-K - Current report
2023/7/15	05:16	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/7/08	05:26	EDGAR2	Form S-1/A - General form for registration of securities..
2023/7/04	07:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/7/04	07:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..